The acute phase response, Immunology Today, vol.15, issue.2, pp.74-80, 1994. ,
DOI : 10.1016/0167-5699(94)90137-6
Acute-phase proteins and other systemic responses to inflammation, N Engl J Med, vol.340, issue.26, pp.448-454, 1999. ,
Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins, J Lipid Res, vol.30, issue.1, pp.39-49, 1989. ,
Low Density Lipoprotein Oxidation and Its Pathobiological Significance, Journal of Biological Chemistry, vol.272, issue.34, pp.20963-20966, 1997. ,
DOI : 10.1074/jbc.272.34.20963
Role of oxidized low density lipoprotein in atherogenesis., Journal of Clinical Investigation, vol.88, issue.6, pp.1785-1792, 1991. ,
DOI : 10.1172/JCI115499
Infection and Inflammation Induce LDL Oxidation In Vivo, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.6, pp.1536-1542, 2000. ,
DOI : 10.1161/01.ATV.20.6.1536
Oxidized Low-Density Lipoprotein Promotes Mature Dendritic Cell Transition from Differentiating Monocyte, The Journal of Immunology, vol.167, issue.7, pp.167-3785, 2001. ,
DOI : 10.4049/jimmunol.167.7.3785
URL : https://hal.archives-ouvertes.fr/inserm-00136264
Mature Dendritic Cell Generation Promoted by Lysophosphatidylcholine, The Journal of Immunology, vol.169, issue.4, pp.1688-1695, 2002. ,
DOI : 10.4049/jimmunol.169.4.1688
URL : https://hal.archives-ouvertes.fr/inserm-00136347
Sensing Environmental Lipids by Dendritic Cell Modulates Its Function, The Journal of Immunology, vol.172, issue.1, pp.54-60, 2004. ,
DOI : 10.4049/jimmunol.172.1.54
URL : https://hal.archives-ouvertes.fr/inserm-00136798
Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes ,
Therapeutic effects of lysophosphatidylcholine in experimental sepsis, Nature Medicine, vol.10, issue.2, pp.161-167, 2004. ,
DOI : 10.1038/nm989
A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M, Proceedings of the National Academy of Sciences, vol.90, issue.18, pp.95-12334, 1998. ,
DOI : 10.1073/pnas.90.18.8392
Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A, Science, vol.293, issue.5530, pp.293-702, 2001. ,
DOI : 10.1126/science.1061781
Enhancement of Antibody Production by Lysophosphatidylcholine and Alkylglycerol, Experimental Biology and Medicine, vol.196, issue.1, pp.69-75, 1991. ,
DOI : 10.3181/00379727-196-43165
Lysolecithin analogs as adjuvants in delayed-type hypersensitivity in mice. II. Studies on the mode of action, European Journal of Immunology, vol.29, issue.5, pp.367-370, 1979. ,
DOI : 10.1002/eji.1830090506
Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism, Clinical and Experimental Immunology, vol.103, issue.2, pp.326-331, 1999. ,
DOI : 10.1016/0014-5793(93)81655-J
LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells, FEBS Letters, vol.37, issue.2-3, pp.217-220, 2000. ,
DOI : 10.1016/S0014-5793(00)01154-6
Aluminum compounds as vaccine adjuvants, Advanced Drug Delivery Reviews, vol.32, issue.3, pp.155-172, 1998. ,
DOI : 10.1016/S0169-409X(98)00008-8
Secretory phospholipase A2 induces dendritic cell maturation, European Journal of Immunology, vol.34, issue.8, pp.2293-2302, 2004. ,
DOI : 10.1002/eji.200324797
URL : https://hal.archives-ouvertes.fr/inserm-00136390
Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis, J Lipid Res, vol.10, issue.2, pp.158-165, 1969. ,